Rein Therapeutics Inc (RNTX) Live Share Price, Invest From India

Rein Therapeutics Inc Stock Performance

as on May 14, 2026 at 2:15 pm IST

Day's Low
Day's High
$1.09
Day's Price Range
$1.20
$1.16
6.03%
Downside
3.45%
Upside
52 Week's Low
52 Week's High
$1.00
52-Week Price Range
$2.40
$1.16
13.79%
Downside
106.90%
Upside

Rein Therapeutics Inc share price movements today

Previous Close: $1.12
Open: $1.14
Volume: 1.3M
Day's Low - High: $1.09 - $1.20
52 Week Low - High: $1.00 - $2.40

Rein Therapeutics Inc Historical Returns

1 Month Return: -31.29 %
3 Month Return: 0 %
1 Year Return: -50.22 %
3 Year Return: 0 %
5 Year Return: 0 %

Rein Therapeutics Inc Stock Fundamentals & Key Indicators

Check Rein Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$89.7M

EPS (TTM)

-1.63

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-139.87%

Rein Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Rein Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Rein Therapeutics Inc	NA	$89.7M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$38.0B	115.2%	71.39	12.55%
BeiGene, Ltd.	NA	$32.7B	NA	71.44	8.94%
Vertex Pharmaceuticals Inc	BUY	$110.4B	106.5%	25.84	35.51%
Regeneron Pharmaceuticals Inc	BUY	$74.7B	40.03%	17.39	29.65%

Stock Returns calculator for Rein Therapeutics Inc Stock including INR - Dollar returns

The Rein Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Rein Therapeutics Inc investment value today

Current value as on today

₹57,862

Returns

-₹42,138

(-42.14%)

Returns from Rein Therapeutics Inc Stock

-₹48,444 (-48.44%)

Dollar Impact

₹6,306 (+6.31%)

Indian Investors' Interest in Rein Therapeutics Inc Stock

Search interest for Rein Therapeutics Inc Stock has increased by 6% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 14, 2026 to May 14, 2026

Change:6% versus previous 30 day period

Rein Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	0	-	-
Operating Income	0	0	0	0	-6	-42	-5	-6	-5	-3
EBITDA	0	0	0	0	-5	0	-5	-6	-5	-3
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	-	-	-	0	-	-
Income Before Tax	0	0	0	0	-5	-42	-5	-6	-5	-32
Income Tax Expense	-	-	-	-	-	0	-1	-	-	0
Net Income	0	0	0	0	-5	-40	-5	-6	-5	-31
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Rein Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	0	0
Operating Income	0	0	0	0	-65	-21
EBITDA	0	0	0	0	-28	-21
Interest Expense	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0
Income Before Tax	0	0	0	0	-64	-50
Income Tax Expense	-	-	-	-	-1	0
Net Income	0	0	0	0	-62	-49
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Rein Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-7	-7	-8	-5	-40	-5	-6	-5	-31
Operating Cash Flow	-10	-5	-8	-3	-4	-6	-6	-3	-3
Investing Cash Flow	0	-	-	-	-	-	-	-	-
Financing Cash Flow	15	-	18	0	0	0	4	1	2
Change in Cash	5	-5	9	-4	-4	-5	-1	-1	0

Rein Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-22	-31	-29	-21	-26	-27	-15	-62	-49
Operating Cash Flow	-20	-27	-26	-20	-23	-24	-19	-22	-19
Investing Cash Flow	-38	24	-2	6	-35	26	16	-	-
Financing Cash Flow	50	2	23	15	55	-	15	17	9
Change in Cash	-8	0	-5	1	-4	1	12	-4	-9

Insights on Rein Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 32.2% return, outperforming this stock by 51.0%
NO EFFECT
Against Peers
In the last 1 year, BeOne Medicines Ltd has given 43.2% return, outperforming this stock by 93.4%
NEGATIVE IMPACT
Price Dip
In the last 1 month, RNTX stock has moved down by -31.3%

About Rein Therapeutics Inc

Rein Therapeutics Inc., a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States. The company's lead product candidate is LTI-03, a peptide, which is in Phase 2 clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF). It also offers LTI-01, a proenzyme that has completed Phase 1b and Phase 2a clinical trials in LPE patients for the treatment of loculated pleural effusion. The company's pipeline also includes preclinical programs targeting cystic fibrosis and a peptide program focused on the caveolin-1 protein for systemic fibrosis indications; and LTI-05, an epithelial sodium channel, which is in preclinical trial phase for the treatment of cystic fibrosis. The company was formerly known as Aileron Therapeutics, Inc. and changed its name to Rein Therapeutics Inc. in February 2007. The company was incorporated in 2001 and is headquartered in Austin, Texas.

Organisation	Rein Therapeutics Inc
Headquarters	12407 N. Mopac Expy., Austin, TX, United States, 78758
Industry	Biotechnology
CEO	Dr. James Brian Windsor Ph.D.
E-voting on shares	Click here to vote

Key Management of Rein Therapeutics Inc

Name	Title
Dr. James Brian Windsor Ph.D.	CEO, President & Director
Mr. Timothy M. Cunningham CPA, M.B.A.	Interim CFO & Principal Accounting Officer
Dr. Cory M. Hogaboam Ph.D.	Chief Scientific Officer
Ms. Jennifer Faigle	Counsel
Mr. Ron Chen	VP of Finance and Corporate Controller

FAQs

What is Rein Therapeutics Inc share price today?

Rein Therapeutics Inc share price today is $1.16 as on May 14, 2026 at 8:45 am IST at the close of the market. Rein Therapeutics Inc share today touched a day high of $1.2 and a low of $1.09.

What is the 52 week high and 52 week low for Rein Therapeutics Inc share?

Rein Therapeutics Inc share touched a 52 week high of $2.4 on May 15, 2025 and a 52 week low of $1 on May 5, 2026. Rein Therapeutics Inc stock price today i.e. May 14, 2026 at 8:45 am IST is closed at $1.16,which is 51.67% down from its 52 week high and 16.00% up from its 52 week low.

What is Rein Therapeutics Inc's market capitalisation today?

Rein Therapeutics Inc market capitalisation is $0.00T as on May 14, 2026 at 8:45 am IST.

How to invest in Rein Therapeutics Inc Stock (RNTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Rein Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Rein Therapeutics Inc Shares that will get you 1.2931 shares as per Rein Therapeutics Inc share price of $1.16 per share as on May 14, 2026 at 8:45 am IST.

What is the minimum amount required to buy Rein Therapeutics Inc Stock (RNTX) from India?

Indian investors can start investing in Rein Therapeutics Inc (RNTX) shares with as little as ₹95.705 or $1 (as of May 14, 2026 at 2:47 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹957.05 in Rein Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on May 14, 2026 at 2:47 pm IST). Based on Rein Therapeutics Inc share’s latest price of $1.16 as on May 14, 2026 at 8:45 am IST, you will get 8.6207 shares of Rein Therapeutics Inc. Learn more about fractional shares .